Damora Therapeutics Announces Inducements Under Nasdaq Rule
30 Mar 2026 //
GLOBENEWSWIRE
Damora Therapeutics Names Jarrett as President & CEO
23 Mar 2026 //
GLOBENEWSWIRE
Damora Therapeutics Reveals 2025 Financials And Corporate Updates
19 Mar 2026 //
GLOBENEWSWIRE
Galecto Announces Name Change to Damora Therapeutics
09 Mar 2026 //
GLOBENEWSWIRE
Galecto Acquires Damora Therapeutics
12 Feb 2025 //
PRESS RELEASE

Market Place
Sourcing Support